Major Players Swap Positions Among Industry Top 50

In the first part of this year’s edition of Generics Bulletin’s annual ranking of the world’s top 50 generics and biosimilars firms, we listed the top ten off-patent companies to see how recent developments had shaken up the table in 2019. (Also see "A Year Of Surprises Shakes Up Industry Top 10" - Generics Bulletin, 19 August, 2020.)

However, major movements were not limited to the industry’s largest 10 players, as demonstrated by the second part of our